These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21641471)

  • 1. Open letter to UK Prime Minister David Cameron and Health Secretary Andrew Lansley on safety of medicines.
    Archibald K; Coleman R; Foster C
    Lancet; 2011 Jun; 377(9781):1915. PubMed ID: 21641471
    [No Abstract]   [Full Text] [Related]  

  • 2. Open letter to prime minister David Cameron and health secretary Andrew Lansley.
    Nicholl DJ; Hilton-Jones D; Palace J; Richmond S; Finlayson S; Winer J; Weir A; Maddison P; Fletcher N; Sussman J; Silver N; Nixon J; Kullmann D; Embleton N; Beeson D; Farrugia ME; Hill M; McDermott C; Llewelyn G; Leonard J; Morris M
    BMJ; 2010 Nov; 341():c6466. PubMed ID: 21081599
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of medicines and the use of animals in research.
    Balkwill F; Whitehead S; Willis P; Gaymond N; Kent A; Page C; Lovell-Badge R; Morris R; Lemon R; Banks D
    Lancet; 2011 Jul; 378(9786):127-8. PubMed ID: 21719093
    [No Abstract]   [Full Text] [Related]  

  • 4. 3 New Biologics To Be Worth $14B in Sales by 2019.
    Adams KT
    Manag Care; 2015 May; 24(5):36-7. PubMed ID: 26117964
    [No Abstract]   [Full Text] [Related]  

  • 5. US lawmakers tackle safety reforms at the FDA.
    Zwillich T
    Lancet; 2007 Jun; 369(9578):1989-90. PubMed ID: 17577942
    [No Abstract]   [Full Text] [Related]  

  • 6. Licensing of medicines.
    Choonara I; Dunne J
    Arch Dis Child; 1998 May; 78(5):402-3. PubMed ID: 9659082
    [No Abstract]   [Full Text] [Related]  

  • 7. Carter urges ministers to acknowledge job cuts.
    Nurs Stand; 2012 May; 26(38):7. PubMed ID: 28072231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open letter to Prime Minister David Cameron on food poverty in the UK.
    Ashton JR; Middleton J; Lang T;
    Lancet; 2014 May; 383(9929):1631. PubMed ID: 24794817
    [No Abstract]   [Full Text] [Related]  

  • 9. Using a drug-safety tool to prevent competition.
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2014 Apr; 370(16):1476-8. PubMed ID: 24738666
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech's next big blowup?
    Stires D
    Fortune; 2002 Mar; 145(6):154. PubMed ID: 11913033
    [No Abstract]   [Full Text] [Related]  

  • 13. Profession celebrated at downing street.
    Nurs Stand; 2012 May; 26(38):9. PubMed ID: 28072198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and medical devices: FDA oversight.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of medicines and the use of animals in research.
    Banerjee A
    Lancet; 2011 Jul; 378(9786):128. PubMed ID: 21719094
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical considerations in drug safety testing.
    Heywood R
    Altern Lab Anim; 1997; 25(4):463-4. PubMed ID: 11657608
    [No Abstract]   [Full Text] [Related]  

  • 17. Congress responds to the IOM drug safety report--in full.
    Psaty BM; Korn D
    JAMA; 2007 Nov; 298(18):2185-7. PubMed ID: 18000202
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug pipeline: Q212.
    DeFrancesco L
    Nat Biotechnol; 2012 Sep; 30(9):817. PubMed ID: 22965044
    [No Abstract]   [Full Text] [Related]  

  • 19. Quest for the best.
    Booth B; Zemmel R
    Nat Rev Drug Discov; 2003 Oct; 2(10):838-41. PubMed ID: 14526387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary by a child psychiatrist in industry on the assessment of drug safety.
    Allen AJ
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):288-91. PubMed ID: 17630860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.